Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD-DTPACE in High-Risk Multiple Myeloma
NCT00577512Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Apr 2007
- Primary completion
- Apr 2009
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of DTPACE in multiple myeloma (MM), sponsored by University of Arkansas. Primary endpoint: Complete Response or Near Complete Response Lasting >= 6 Months at 12 months. Started Apr 2007; status: completed.
02
Drugs
DTPACE
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00577512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577512.